Image-guided interventions: Fundamentals of radiofrequency tumor ablation

Interventional Oncology: Principles and Practice

Volumn , Issue , 2008, Pages 55-66

  Hines Peralta, Andrew ^a   Nahum Goldberg, S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932616625     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511722226.006     Document Type: Chapter

References (107)

1. Dupuy D, Goldberg S. Image-guided radiofrequency tumor ablation: Challenges and opportunities-Part II. J Vasc Interv Radiol 2001; 12: 1135-1148.
2. Lencioni R, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967.
3. Dodd GD, 3rd, et al. Minimally invasive treatment of malignant hepatic tumors: At the threshold of a major breakthrough. Radiographics 2000; 20(1): 9-27.
4. Lencioni R, et al. Early stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234(3): 961-967.
5. Kim YK, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: Evaluation of therapeutic efficacy and safety. AJR Am J Roentgenol 2006; 186(5 Suppl): S261-268.
6. Colella G, et al. Hepatocellular carcinoma: Comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 1998; 11(Suppl 1): S193-196.
7. Gervais DA, et al. Radiofrequency ablation of renal cell carcinoma: Part 1; Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185(1): 64-71.
8. Pavlovich CP, et al. Percutaneous radio frequency ablation of small renal tumors: Initial results. J Urol 2002; 167(1): 10-15.
9. Gervais DA, et al. Radiofrequency ablation of renal cell carcinoma: Part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005; 185(1): 72-80.
10. Pautler SE, et al. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors. Can J Urol 2001; 8: 1330-1333.
11. Arzola J, Baughman SM, Hernandez J, et al. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology 2006 Nov; 68(5): 983-987.
12. Gervais DA, Arellano RS, and Mueller PR. Percutaneous radiofrequency ablation of renal cell carcinoma. Eur Radiol 2005; 15(5): 960-967.
13. Goldberg SN and Dupuy EE. Image-guided radiofrequency tumor ablation: Challenges and opportunities-Part I. J Vasc Interv Radiol 2001; 12: 1021-1032.
14. Montgomery RS, et al. Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR Am J Roentgenol 2004; 182(3): 657-661.
15. Hakime A, Hines-Peralta AU, Peddy H, et al. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: Study in mice. Radiology. 2007 Aug; 244(2): 464-470.
16. Hines-Peralta A, Sukhatme V, Atkins M, et al. Arsenic trioxide and radiofrequency ablation: Improved tumor destruction in three animal models. Radiology 2006 Jul; 240(1): 82-89.
17. Ahmed M, Liu Z, Lukyanov AN, et al. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: Effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology 2005 May; 235(2): 469-477.
18. Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 2002 Jul; 179(1): 93-101.
19. Goldberg SN, et al. Percutaneous tumor ablation: Increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002; 222(3): 797-804.
20. Goldberg SN, et al. Percutaneous tumor ablation: increased coagulation necrosis with combined radiofrequency and percutaneous doxorubicin injection. Radiology 2001; 220: 420-427.
21. Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 2006 Mar; 16(3): 661-669.
22. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 1999 Apr; 20(2): 47-53.
23. Inoue Y, Miki C, Hiro J, et al. Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: A preliminary study. Oncol Rep 2005 Dec; 14(6): 1571-1576.
24. Qian J, Feng GS, and Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003 Sep; 9(9): 1885-1891.
25. Kitamoto M, Imagawa M, Yamada H, et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: Comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 2003 Oct; 181(4): 997-1003.
26. Shen SQ, Xiang JJ, Xiong CL, et al. Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology 2005 Sep-Oct; 52(65): 1403-1407.
27. Yamakado K, Nakatsuka A, Akeboshi M, et al. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival. Oncol Rep 2004 Jan; 11(1): 105-109.
28. Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: Treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002 Dec; 13(12): 1225-1232.
29. Bloomston M, Binitie O, Fraiji E, et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002 Sep; 68(9): 827-831.
30. Horkan C, et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology 2005; 235(1): 81-8.
31. Jain SK, et al. Percutaneous radiofrequency ablation of pulmonary malignancies: Combined treatment with brachytherapy. AJRAmJ Roentgenol 2003; 181(3): 711-715.
32. Grieco CA, et al. Percutaneous image-guided thermal ablation and radiation therapy: Outcomes of combined treatment for 41 patients with inoperable stage I/II nonsmall-cell lung cancer. J Vasc Interv Radiol 2006; 17(7): 1117-1124.
33. Dupuy DE, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small-cell lung cancer. Chest 2006; 129(3): 738-745.
34. Ricke J, Wust P, Stohlmann A, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: Phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004 Apr 1; 58(5): 1496-1505.
35. Kurokohchi K, et al. Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(10): 1426-1432.
36. Shankar S, vanSonnenberg E, Morrison PR, et al. Combined radiofrequency and alcohol injection for percutaneous hepatic tumor ablation. AJR Am J Roentgenol 2004 Nov; 183(5): 1425-1429.
37. Kurokohchi K, Watanabe S, Masaki T, et al. Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma. Int J Oncol 2002 Oct; 21(4): 841-846.
38. Watanabe S, et al. Enlargement of thermal ablation zone by the combination of ethanol injection and radiofrequency ablation in excised bovine liver. Int J Oncol 2004; 24(2): 279-284.
39. Luo BM, Wen YL, Yang HY, et al. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma. World J Gastroenterol 2005 Oct 28; 11(40): 6277-6280.
40. Sakaguchi Y, Kudo M, Fukunaga T, et al. Lowdose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma. Intervirology 2005 Jan-Feb; 48(1): 64-70.
41. Goldberg SN, Gazelle GS, and Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, technqiues, and diagnostic imaging guidance. Am J Radiol 2000; 174: 323-331.
42. AhmedMand Goldberg SN. Thermal ablation therapy for hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13(9 Suppl): S231-244.
43. Giorgio A, et al. Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center. AJR Am J Roentgenol 2005; 184(1): 207-211.
44. Kim YK, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: Evaluation of therapeutic efficacy and safety. AJR Am J Roentgenol 2006; 186(5 Suppl): S261-268.
45. ZevasNand Kuwayama A. Pathologic analysis of experimental thermal lesions: Comparison of induction heating and radiofrequency electrocoagulation. J Neurosurg 1972; 37: 418-422.
46. Seegenschmiedt M, Brady L, and Sauer R. Interstitial thermoradiotherapy: Review on technical and clinical aspects. Am J Clin Oncol 1990; 13: 352-363.
47. van der Zee J, Dutch Deep Hyperthermia Group. et al., Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000; 355(9210): 1119-1125.
48. Trembley B, Ryan T, and Strohbehn J. "Interstitial hyperthermia: Physics, biology, and clinical aspects. " In Hyperthermia and Oncology, Vol. 3 Utrecht: VSP 1992, pp. 11-98.
49. Gazelle GS, et al., Tumor ablation with radiofrequency energy. Radiology 2000; 217: 6333-6346.
50. Mertyna P, Hines-Peralta A, Liu Z, et al. Radiofrequency ablation: Variability in heat sensitivity in tumors and tissues. J Vasc Interv Radiol. 2007 May; 18(5): 647-654.
51. Goldberg SN, Gazelle GS, Compton CC, et al. Treatment of intrahepatic malignancy with radiofrequency ablation: Radiologic-pathologic correlation. Cancer 2000; 88: 2452-2463.
52. LiszczakTM, Hedley-Whyte ET, Adams JF, et al. Limitations of tetrazolium salts in delineating infracted brain. Acta Neuropathol (Berl) 1984; 65: 150-157.
53. Pennes H. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1948: 93-122.
54. Rossi S, Buscarini E, and Garbagnati F. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170: 1015-1022.
55. de Baere T, et al. Radiofrequency liver ablation: Experimental comparative study of water-cooled versus expandable systems. AJRAm J Roentgenol 2001; 176(1): 187-192.
56. Haemmerich DG, et al., A device that allows for multiple simultaneous radiofrequency (RF) ablations in separated areas of the liver with impedance-controlled cool-tip probes: An ex-vivo feasibility study [abstract]. Radiology 2002; 225(p): 242.
57. Desinger K, et al. Interstitial bipolar RF-thermotherapy therapy by planning by computer simulation and MRImonitoring-a new concept for minimally invasive procedures. Proc SPIE 1999; 3249: 147-160.
58. Miao Y, et al. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol 2000; 35(7): 438-444.
59. Solbiati L, Ierace T, Goldberg SN. Percutaneous USguided RF tissue ablation of liver metastases: Long-term follow-up. Radiology 1997; 202: 195-203.
60. Goldberg SN, Gazelle GS, Dawson SL, et al. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1995; 2: 670-674.
61. Miao Y, Ni Y, Yu J, et al. An ex vivo study on radiofrequency tissue ablation: Increased lesion size by using an "expandable-wet" electrode. Eur Radiol 2001; 11: 1841-1847.
62. Berber E, et al. Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc 2000; 14(9): 799-804.
63. Ritz JP, Lehmann KS, Isbert C, et al. In-vivo evaluation of a novel bipolar radiofrequency device for interstitial thermotherapy of liver tumors during normal and interrupted hepatic perfusion. J Surg Res 2006 Jun 15; 133(2): 176-184.
64. Hines-Peralta A, Hollander CY, Solazzo S, et al. Hybrid radiofrequency and cryoablation device: Preliminary results in an animal model. J Vasc Interv Radiol. 2004 Oct; 15(10): 1111-1120.
65. Haemmerich DG, Lee FTJ, Chachati L, et al. A device that allows for multiple simultaneous radiofrequency (RF) ablations in separated areas of the liver with impedance-controlled cool-tip probes: An ex vivo feasibility study. Radiology 2002; 225: 242.
66. Goldberg SN, Gazelle GS, Solbiati L, et al. Radiofrequency tissue ablation: Increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3: 636-644.
67. Lorentzen T. A cooled needle electrode for radiofrequency tissue ablation: Thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol 1996; 3: 556-563.
68. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radiofrequency by using a clustered, internally-cooled electrode technique: Laboratory and clinical experience in liver metastases. Radiology 1998; 209: 371-379.
69. Curley MG, Hamilton PS. Creation of large thermal lesions in liver using saline-enhanced RF ablation. Proc 19th International Conference IEEE/EMBS 1997: 2516-2519.
70. Livraghi T, Goldberg SN, Monti F, et al. Salineenhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202: 205-210.
71. Miao Y, et al. An ex vivo study on radiofrequency tissue ablation: Increased lesion size by using an "expandablewet" electrode. Eur Radiol 2001; 11(9): 1841-1847.
72. Ahmed M, Lobo SM, Weinstein J, et al. Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model. J Vasc Interv Radiol 2002; 12: 717-724.
73. Goldberg SN, Stein M, Gazelle GS, et al. Percutaneous radiofrequency tissue ablation: Optimization of pulsed-RF technique to increase coagulation necrosis. JVIR 1999; 10: 907-916.
74. Haemmerich DG, Lee FTJ, Mahvi DM, et al. Multiple probe radiofrequency: Rapid switching versus simultaneous power application in a computer model. Radiology 2002; 225(p): 639.
75. Lee FT Jr., Haemmerich D, Wright AS, et al. Multiple probe radiofrequency ablation: Pilot study in an animal model. J Vasc Interv Radiol 2003 Nov; 14(11): 1437-1442.
76. Brace CL, et al. Microwave ablation with a single smallgauge triaxial antenna: In vivo porcine liver model. Radiology 2007; 242(2): 435-440.
77. Dong B, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: Results in 234 patients. Am J Roentgenol 2003; 180: 1547-1555.
78. Dachman AH, et al. US-guided percutaneous laser ablation of liver tissue in a chronic pig model. Radiology 1990; 176: 129-133.
79. Jolesz FA and Hynynen K. Magnetic resonance imageguided focused ultrasound surgery. Cancer 2002; 8(Suppl 1): S100-112.
80. Hoffmann NE and Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60: 40-49.
81. Ahmed M, et al. Radiofrequency ablation: Effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004; 230(3): 761-767.
82. Solazzo SA, et al. Radiofrequency ablation: importance of background tissue electrical conductivity-an agar phantom and computer modeling study. Radiology 2005; 236(2): 495-502.
83. Goldberg SN, Ahmed M, Gazelle GS, et al. Radiofrequency thermal ablation with adjuvant saline injection: Effect of electrical conductivity on tissue heating and coagulation. Radiology 2001; 219: 157-165.
84. Goldberg SN, et al. Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9(1 Pt 1): 101-111.
85. Patterson EJ, et al. Radiofrequency ablation of porcine liver in vivo: Effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227(4): 559-565.
86. Lu DS, Raman SS, Vodopich DJ, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: Assessment of the "heat sink" effect. AJR 2002; 178: 47-51.
87. Liu Z, Ahmed M, Weinstein Y, et al. Characterization of the RF ablation-induced 'oven effect': The importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia 2006 Jun; 22(4): 327-342.
88. Yamasaki T, Kimura T, Kurokawa F, et al. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol 2005 Feb; 40(2): 171-178.
89. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217: 119-126.
90. Frich L, Mala T, Gladhaug IP. Hepatic radiofrequency ablation using perfusion electrodes in a pig model: Effect of the Pringle manoeuvre. Eur J Surg Oncol 2006 Jun; 32(5): 527-532.
91. Shen SQ, Xiang JJ, Xiong CL, et al. Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology 2005 Sep-Oct; 52(65): 1403-1407.
92. Gasparini D, Sponza M, Marzio A, et al. Combined treatment, TACE and RF ablation, in HCC: Preliminary results. Radiol Med 2002 Nov-Dec; 104(5-6): 412-420.
93. Wang YB, Chen MH, Yan K, et al. Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison with transcatheter arterial chemoembolization alone. Qual Life Res 2007 Apr; 16(3): 389-397; Epub 2006 Nov 17.
94. Kurokohchi K, Hosomi N, Yoshitake A, et al. Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanollipiodol injection and radiofrequency ablation. Oncol Rep 2006 Nov; 16(5): 1067-1070.
95. Pacella CM, Bizzarri G, Cecconi P, et al. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001 Jun; 219(3): 669-678.
96. Bilchik AJ, Wood TF, Chawla SP, et al. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil. Clin Colorectal Cancer 2001 May; 1(1): 36-42.
97. Becker G, Soezgen T, Olschewski M, et al. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005 Oct 21; 11(39): 6104-6109.
98. Li YH, Wang CS, Liao LY, et al. Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection. J Formos Med Assoc 2003 Mar; 102(3): 141-146.
99. Kamada K, Kitamoto M, Aikata H, et al. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am J Surg 2002 Sep; 184(3): 284-290.
100. Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized control study. Cancer 2001 Sep 15; 92(6): 1516-1524.
101. Allgaier HP, Deibert P, Olschewski M, et al. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection-a single-center analysis including 132 patients. Int J Cancer 1998 Dec 18; 79(6): 601-605.
102. Tanaka K, Nakamura S, Numata K, et al. The long-term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998 Jan 1; 82(1): 78-85.
103. Lencioni R, Paolicchi A, Moretti M, et al. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: Local therapeutic effect and longterm survival rate. Eur Radiol 1998; 8(3): 439-444.
104. Grieco CA, Simon CJ, Mayo-Smith WW, et al. Percutaneous image-guided thermal ablation and radiation therapy: Outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006 Jul; 17(7): 1117-4424.
105. Kim SK, Rhim H, Kim YS, et al. Radiofrequency thermal ablation of hepatic tumors: Pitfalls and challenges. Abdom Imaging 2005 Nov-Dec; 30(6): 727-733.
106. Kawamoto S, Permpongkosol S, Bluemke DA, et al. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: Role of CT and MR imaging. Radiographics 2007 Mar-Apr; 27(2): 343-355.
107. Wile GE, Leyendecker JR, Krehbiel KA, et al. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics 2007 Mar-Apr; 27(2): 325-339.